Skip to content
cask.news
← Browse all apps

Ugene vs Jalview

Side-by-side comparison for macOS

Ugene

8.0
Science

Free open-source cross-platform bioinformatics software

Jalview

8.0
Science

Multiple sequence alignment editor, visualiser, analysis and figure generator

Metric Ugene Jalview
Category Science Science
AI Score 8.0 8.0
30-day Installs 10 24
90-day Installs 18 73
365-day Installs 59 299
Version 53.1 2.11.5.1
Auto-updates No No
Deprecated No No
GitHub Stars 261
GitHub Forks 68
Open Issues 16
License GPL-2.0
Language C++
Last GitHub Commit 2mo ago
First Seen Nov 4, 2021 Jul 23, 2019

Reviews

Ugene

Ugene is a comprehensive bioinformatics tool designed for sequence analysis and editing. It offers a wide range of features for handling biological data, making it a valuable resource for researchers and biologists in the field of genomics and molecular biology.

Ugene provides tools for analyzing and editing biological sequences, supporting various formats and tasks in bioinformatics research.

Pros

  • + Free and open-source, promoting accessibility and customization.
  • + Supports multiple sequence formats, enhancing versatility.
  • + Cross-platform compatibility, ensuring broad usability.

Cons

  • - Lacks auto-update functionality, requiring manual checks for updates.
  • - Limited community discussion, which may affect user support.

Jalview

Jalview is a specialized tool for editing, visualizing, and analyzing multiple sequence alignments, ideal for researchers in molecular biology and evolutionary studies. It offers user-friendly features for generating figures and conducting detailed analyses, making it a valuable resource for biologists and bioinformaticians.

Jalview enables users to create, edit, analyze, and visualize multiple sequence alignments, which are crucial for molecular biology research.

Pros

  • + Specialized for molecular biology and bioinformatics tasks
  • + User-friendly interface for non-experts
  • + Strong visualization and figure generation capabilities

Cons

  • - No auto-update feature
  • - Niche appeal limits its broader adoption